Medical Evaluation for Gynecomastia: Causes, Diagnosis, and Next Steps

Gynecomastia, or enlarged male breast tissue, is a common concern that often prompts a medical evaluation for gynecomastia to determine cause and appropriate care. Detected intent: Informational.

Why a medical evaluation for gynecomastia matters

Male breast enlargement can be caused by benign, reversible factors as well as conditions that require urgent care. A clinical assessment helps separate gynecomastia (glandular proliferation) from pseudo-gynecomastia (fat accumulation), detects signs of systemic disease such as liver or thyroid dysfunction, and screens for rare but important causes like breast cancer or testicular tumors. Early and accurate diagnosis prevents unnecessary procedures, leads to correct treatment, and addresses emotional or psychosocial impact.

Key terms and related concepts

• Gynecomastia: benign enlargement of male breast glandular tissue.
• Pseudo-gynecomastia: adipose tissue increase without glandular proliferation.
• Hormonal imbalance: altered testosterone-to-estrogen ratio.
• Associated conditions: liver disease, kidney failure, thyroid disorders, Klinefelter syndrome.
• Relevant tests: serum hormone panel, liver function tests, imaging (ultrasound, mammogram), biopsy when indicated.

When to see a doctor for male breast enlargement

Seek evaluation if breast tissue is painful, rapidly enlarging, asymmetric, accompanied by nipple discharge or a palpable lump, or when systemic symptoms (weight loss, fatigue, testicular changes) appear. Persistent enlargement beyond pubertal years, or new onset in older adults, also warrants assessment. Assessment tasks prioritize identifying reversible causes such as medication effects or endocrine disorders.

Gynecomastia causes and diagnosis

Common causes include physiologic changes (neonatal, pubertal, elderly), medications (anti-androgens, some psychotropics, anabolic steroids), endocrine disorders (hypogonadism, hyperthyroidism), liver or renal disease, and rare neoplasms. Diagnosis combines clinical history, focused physical exam distinguishing glandular vs fatty tissue, and selective tests: serum testosterone, estradiol, LH, FSH, beta-hCG, prolactin, TSH, and liver/renal panels. Imaging—typically ultrasound—helps evaluate suspicious focal masses.

What an evaluation typically includes

• History: onset, duration, pain, medication and supplement review (including anabolic steroids and herbal products), alcohol use, and systemic symptoms.
• Physical exam: size, consistency, symmetry, nipple discharge, axillary nodes, testicular exam.
• Targeted labs and imaging based on findings.
• Referral to endocrinology, surgery, or oncology when indicated.

For patient-facing guidance on common approaches, see the NHS guidance on gynecomastia: NHS: Gynecomastia.

GYNECOMASTIA EVALUATION CHECKLIST

This named checklist standardizes clinical assessment and communication.

1. Gather history: medications, supplements, substance use, pubertal status, systemic symptoms.
2. Yield physical exam: bilateral comparison, glandular vs fatty tissue, nipple discharge, lymph nodes, testicular exam.
3. Assess initial labs: testosterone, estradiol, LH, FSH, TSH, LFTs, beta-hCG as indicated.
4. Note imaging needs: ultrasound for focal masses; mammogram or biopsy if malignancy suspected.
5. Consider referral: endocrinology for hormonal causes; surgery for persistent symptomatic cases.
6. Arrange follow-up: document plan, watchful waiting timeline, or treatment start.

Short real-world scenario

A 17-year-old male reports breast fullness for 6 months with mild tenderness. History reveals no drug use. Examination shows bilateral, symmetric, soft glandular tissue <3 cm. Management: reassurance, set a 6–12 month follow-up because pubertal gynecomastia often resolves, and avoid anabolic steroids. If enlargement persisted beyond 12–18 months or increased in size, order labs and ultrasound and consider endocrine referral.

Practical tips for patients and clinicians

• Review all medications and over-the-counter supplements—many agents can cause gynecomastia or alter hormones.
• Use targeted lab testing driven by history and exam rather than broad, low-yield panels.
• If the exam suggests a discrete mass, prioritize ultrasound before empirical treatment.
• Document size and symptoms over time; many cases in adolescents resolve without intervention.
• Address psychosocial impact; offer counseling or support resources when body image or social functioning is affected.

Common mistakes and trade-offs

Overtesting can cause anxiety and unnecessary costs, but undertesting may miss serious causes. Common mistakes include confusing simple fatty enlargement with glandular proliferation, failing to review medications, and delaying evaluation of unilateral, hard, or rapidly growing masses. Balance diagnostic thoroughness with stepwise testing: start with history and exam, then add labs and imaging selectively.

Core cluster questions (for related articles and internal linking)

• How is gynecomastia differentiated from pseudo-gynecomastia?
• What lab tests are most useful when evaluating male breast enlargement?
• When should imaging or biopsy be performed for a breast mass in men?
• Which medications most commonly cause gynecomastia?
• What are the medical and surgical treatment options for persistent gynecomastia?

When treatment is considered and trade-offs

Treatment decisions weigh symptom severity, duration, and underlying cause. Medical therapy (e.g., selective estrogen receptor modulators) can reduce gland size in some cases but carries side effects. Surgical options provide definitive cosmetic results but involve recovery and risks. When the cause is a reversible medication or endocrine disorder, addressing that cause first may avoid other interventions.

Frequently asked questions

What happens during a medical evaluation for gynecomastia?

The evaluation includes a focused history about onset, medications and substance use; a physical exam to distinguish glandular tissue from fat and to check for concerning features; targeted laboratory tests (hormones, liver/renal function) when indicated; and imaging—usually ultrasound—if a discrete mass or asymmetry is present. Referral to specialists is based on findings.

Is gynecomastia a sign of cancer?

Male breast cancer is uncommon but possible. Red flags are a single hard mass, rapid growth, skin changes, nipple retraction, or bloody discharge. These features prompt imaging and biopsy to exclude malignancy.

Can medications cause gynecomastia and should they be stopped?

Yes. Several drugs and supplements can cause gynecomastia. Clinicians should review potential culprits and, when safe, consider stopping or substituting the offending agent before pursuing invasive treatments.

How long will evaluation and treatment take to show results?

Timeline varies: physiologic pubertal gynecomastia often resolves within 6–18 months. Medical therapies may take months to show improvement. Surgical correction has immediate size change but requires weeks of recovery.

When is referral to a specialist recommended?

Refer to endocrinology for abnormal hormone results or suspected systemic causes, and to breast surgery or plastic surgery for persistent, symptomatic, or cosmetic concerns. Oncology referral is indicated when imaging or biopsy suggests malignancy.

This article includes practical steps, a named checklist, a scenario, core cluster questions for further content, and a trustworthy external reference to support standard clinical guidance. Use a stepwise, evidence-informed approach to ensure accurate diagnosis and to choose appropriate, patient-centered management.